CVS Group’s (CVSG) “Buy” Rating Reiterated at Berenberg Bank

Berenberg Bank reiterated their buy rating on shares of CVS Group (LON:CVSG) in a research note released on Thursday,Digital Look reports. They currently have a GBX 2,000 price objective on the stock.

Separately, Jefferies Financial Group cut shares of CVS Group to a “hold” rating and decreased their price target for the stock from GBX 1,420 to GBX 1,350 in a report on Thursday, July 9th. Four research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of GBX 1,710.

CVS Group Price Performance

CVS Group stock opened at GBX 1,196 on Thursday. The stock’s fifty day moving average price is GBX 1,222.74 and its two-hundred day moving average price is GBX 1,247.08. The company has a debt-to-equity ratio of 92.34, a current ratio of 1.07 and a quick ratio of 0.90. CVS Group has a one year low of GBX 1,062 and a one year high of GBX 1,648. The firm has a market cap of £827.63 million, a PE ratio of 17.36, a price-to-earnings-growth ratio of 1.77 and a beta of 1.06.

CVS Group declared that its board has authorized a stock buyback program on Tuesday, May 26th that authorizes the company to repurchase 0 outstanding shares. This repurchase authorization authorizes the company to repurchase shares of its stock through open market purchases. Stock repurchase programs are typically an indication that the company’s management believes its shares are undervalued.

Insiders Place Their Bets

In related news, insider Scott Morrison bought 987 shares of the stock in a transaction that occurred on Wednesday, May 27th. The shares were acquired at an average cost of GBX 1,270 per share, with a total value of £12,534.90. 1.43% of the stock is owned by corporate insiders.

About CVS Group

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.